EyePoint, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
EyePoint, Inc. (EYPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 80.00% for the 12-month period ending 2016-06-30, per its 10-K filed 2016-09-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2016-09-13
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2016 was 80.00%, a 13.98% decline from fiscal 2015.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2015 was 93.00%, a 3.12% decline from fiscal 2014.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2014 was 96.00%, a 2.04% decline from fiscal 2013.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2013 was 98.00%, a 1.03% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month |
|---|---|---|---|
| 2016-06-30 | 80.00% 10-K · filed 2016-09-13 | ||
| 2016-03-31 | 80.00% 10-Q · filed 2016-05-06 | ||
| 2015-12-31 | 80.00% 10-Q · filed 2016-02-09 | ||
| 2015-06-30 | 93.00% 10-K · filed 2016-09-13 | ||
| 2015-03-31 | 93.00% 10-Q · filed 2015-05-08 | ||
| 2014-12-31 | 93.00% 10-Q · filed 2015-02-06 | ||
| 2014-06-30 | 96.00% 10-K · filed 2016-09-13 | ||
| 2014-03-31 | 96.00% 10-Q · filed 2014-05-14 | ||
| 2013-12-31 | 96.00% 10-Q · filed 2014-02-12 | ||
| 2013-06-30 | 98.00% 10-K · filed 2015-09-10 | ||
| 2012-06-30 | 97.00% 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |